Relzomostat is a MetAP2 inhibitor, specifically targeting methionine aminopeptidase 2. It holds potential in research concerning obesity, type 2 diabetes, and other conditions associated with obesity.
Molecular Weight:
470.558
CAS Number:
[2081078-92-2]
Formula:
C24H36F2N2O5
Target:
Aminopeptidase|||Others
T39488
T39488
* VAT and and shipping costs not included. Errors and price changes excepted
